Timo Minssen

Søgeresultater

• That Pill Is Watching You - Privacy And Hackability Of Ingestible Electronic Sensors

  Sara Gerke, Timo Minssen, Helen Yu & Glenn Cohen

  03/09/2019

  1 element af Mediedækning

  Presse/medie

• At NY Genome Center, Legal Expert Presents Ethical Dilemmas in Gene Editing

  Timo Minssen

  29/08/2019

  1 element af Mediedækning

  Presse/medie

• En NY Genome Center, un experto legal presenta dilemas éticos en la edición de genes

  Timo Minssen

  29/08/2019

  1 element af Mediedækning

  Presse/medie

• US reform plan for patents raises innovation concerns

  Timo Minssen

  09/07/2019

  1 Mediebidrag

  Presse/medie

• Artificiell intelligens– löftesrik teknik med etiska utmaningar

  Timo Minssen

  02/06/2019

  1 Mediebidrag

  Presse/medie

• On antibiotics, capital gains, China, America’s civil war, unicorns, ties - Letters to the editor

  Jonathan Darrow & Timo Minssen

  25/05/2019

  1 Mediebidrag

  Presse/medie

• Why the GMO Regulations in Europe are ‘Not Fit for Purpose’

  Timo Minssen

  27/02/2019

  1 Mediebidrag

  Presse/medie

• Locus licenses CRISPR tech to Janssen in potential $818m deal

  Timo Minssen

  09/01/2019

  1 Mediebidrag

  Presse/medie

• Når man blander kunstig intelligens med biomedicin, så er juraen essential - Interview with CeBIL Director Timo Minssen

  Timo Minssen

  11/10/2018

  1 Mediebidrag

  Presse/medie

• En klodset administrativ revolution

  Timo Minssen & Ryan Long

  01/06/2018

  1 Mediebidrag

  Presse/medie

• Medicinalindustri vil fortsat skjule oplysninger om forsøg

  Timo Minssen

  01/02/2018

  1 Mediebidrag

  Presse/medie

• Mixed views on Broad’s fate after EPO revokes CRISPR patent

  Timo Minssen

  18/01/2018

  1 Mediebidrag

  Presse/medie

• Novo kaster millioner efter retsopgør med Kåre Schultz og Teva

  Timo Minssen & Karin Beukel

  17/01/2018

  1 Mediebidrag

  Presse/medie

• Podcast-interview: Unlocking the full potential of Open Innovation in the Life Sciences through a classification system, see: https://www.ebe-biopharma.eu/wp-content/uploads/2018/01/EBE_Open-Innovation-Podcast-3.mp3

  Timo Minssen & Niclas Nilsson

  14/12/2017

  1 Mediebidrag

  Presse/medie

• LSPN Europe 2017: Broad had ‘no clue’ about CRISPR licensing in agriculture

  Timo Minssen

  07/12/2017

  1 Mediebidrag

  Presse/medie

• GSK's selvmordssag kan sætte gang i medicinspekulanter

  Timo Minssen

  17/05/2017

  1 Mediebidrag

  Presse/medie

• Topadvokats selvmord kan sende medicinspekulanter på pengejagt

  Timo Minssen

  17/05/2017

  1 Mediebidrag

  Presse/medie

• Patentstrid fortsætter for Novo

  Timo Minssen

  05/08/2016

  1 Mediebidrag

  Presse/medie

• Gennemsigtighed i menneskeforsøg kan standse udvikling af ny medicin

  Timo Minssen

  30/06/2016

  1 Mediebidrag

  Presse/medie

• Novo på vej mod sejr i patentstrid

  Timo Minssen

  29/06/2016

  1 Mediebidrag

  Presse/medie

• Novo styrer mod overraskende sejr i patentkrig: Berlingske Business

  Timo Minssen

  29/06/2016

  1 Mediebidrag

  Presse/medie

• Novo vingeskudt i patentslagsmål: Berlingske Business

  Timo Minssen

  15/03/2016

  1 Mediebidrag

  Presse/medie

• Gennemsigtighed kan være et problem

  Timo Minssen

  01/08/2015

  1 Mediebidrag

  Presse/medie

• Små firmaer kan få et vanskeligt liv under den nye patentdomstol.

  Timo Minssen

  10/04/2014

  1 Mediebidrag

  Presse/medie

• USA sætter jagten ind på industrien, (interview concerning EU and US procedures regarding pharmaceutical patent settlements).

  Timo Minssen

  08/01/2014

  1 Mediebidrag

  Presse/medie